UPDATE: Goldman Sachs Starts Revance Therapeutic (RVNC) at Buy
Tweet Send to a Friend
(Updated - September 22, 2022 5:16 AM EDT)
Goldman Sachs analyst Chris Shibutani initiates coverage on Revance Therapeutic (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani initiates coverage on Revance Therapeutic (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
